Milestone Scientific (MLSS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2004 | 12-2003 | 12-2002 | 12-2001 | 12-2000 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,997 | -2,413 | -2,440 | -3,990 | -7,510 |
| Depreciation Amortization | 102 | 335 | 410 | 430 | 710 |
| Accounts receivable | -34 | -150 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | -1,016 | 906 | N/A | N/A | N/A |
| Other Working Capital | -1,423 | 1,246 | 1,330 | 1,820 | 590 |
| Other Operating Activity | 1,083 | -745 | 30 | 360 | 3,370 |
| Operating Cash Flow | $-4,285 | $-821 | $-670 | $-1,380 | $-2,840 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -351 | -35 | -70 | -10 | -50 |
| Purchase Of Investment | -70 | N/A | N/A | N/A | N/A |
| Purchase Sale Intangibles | -76 | N/A | N/A | N/A | N/A |
| Other Investing Activity | -76 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-496 | $-35 | $-70 | $-10 | $-50 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 1,081 | N/A | N/A | N/A |
| Debt Repayment | -50 | -122 | N/A | N/A | N/A |
| Common Stock Issued | N/A | 249 | N/A | N/A | N/A |
| Other Financing Activity | 7,869 | -358 | 740 | 1,230 | 2,820 |
| Financing Cash Flow | $7,819 | $850 | $740 | $1,230 | $2,820 |
| Beginning Cash Position | 3 | 10 | 10 | 170 | 240 |
| End Cash Position | 3,041 | 3 | 10 | 10 | 170 |
| Net Cash Flow | $3,038 | $-6 | $-6 | $-150 | $-70 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,285 | -821 | -670 | -1,380 | -2,840 |
| Capital Expenditure | -351 | -35 | N/A | N/A | N/A |
| Free Cash Flow | -4,635 | -856 | -670 | -1,380 | -2,840 |